Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenation
Artificial Organs · 2023-10 · 47 (10) · 1654-1662
DOI: 10.1111/aor.14604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Organs, online erschienen am 07.07.2023. Verfasst von Christian Noe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Medical Intensive Care, Faculty of Medicine, University of Freiburg Medical Center, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Respiratory Insufficiency. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Mobilisation
Abstract (Originalsprache)
Background
Mobilization is important in longer courses in intensive care unit (ICU), typical for patients requiring venovenous extracorporeal membrane oxygenation (V‐V ECMO). For patients supported with ECMO, especially out‐of‐bed mobilizations improve outcome. We hypothesized that utilization of a dual lumen cannula (DLC) for V‐V ECMO would facilitate out‐of‐bed mobilization compared to single lumen cannulas (SLC).
Methods
Retrospective single center registry study including all V‐V ECMO patients cannulated between 10/2010 and 05/2021 for respiratory failure.
Results
The registry included 355 V‐V ECMO patients (median age 55.6 years, 31.8% female, 27.3% with preexisting pulmonary disease), 289/355 (81.4%) primary cannulated with DLC, and 66/355 (18.6%) using SLC. Both groups had similar pre‐ECMO characteristics. The runtime of the first ECMO cannula was significantly longer in DLC compared to SLC (169 vs. 115 h, p = 0.015). The frequency of prone positioning during V‐V ECMO was similar in both groups (38.4 vs. 34.8%, p = 0.673). There was no difference in in‐bed mobilization (41.2 vs. 36.4%, for DLC and SLC, respectively, p = 0.491). Patients with DLC were more often mobilized out‐of‐bed (25.6 vs. 12.1%, OR 2.495 [95% CI 1.150 to 5.268], for DLC and SLC, respectively, p = 0.023). Hospital survival was similar in both groups (46.4 vs. 39.4%, for DLC and SLC, respectively, p = 0.339).
Conclusion
Patients cannulated with a dual lumen cannula for V‐V ECMO support were significantly more often mobilized out‐of‐bed. Since mobilization is important in prolonged ICU courses typical for ECMO patients, this might be an important benefit. Other benefits of DLC were the longer runtime of the initial cannula set and fewer suction events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Medical Intensive Care, Faculty of Medicine, University of Freiburg Medical Center, University of Freiburg, Freiburg, Germany.
- Department of Medicine IV - Nephrology and Primary Care, Faculty of Medicine, University of Freiburg Medical Center, University of Freiburg, Freiburg, Germany.
- Department of Cardiology and Angiology I, Faculty of Medicine, University of Freiburg Medical Center, University of Freiburg, Freiburg, Germany.
ORCID-Profile: Felix A Rottmann, Alexander Supady, Dawid L Staudacher
Zitieren
APA
Noe, C., Rottmann, F. A., Bemtgen, X., Supady, A., Wengenmayer, T., & Staudacher, D. L. (2023). Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenation. Artificial Organs, 47(10), 1654-1662. https://doi.org/10.1111/aor.14604
Vancouver
Noe C, Rottmann FA, Bemtgen X, Supady A, Wengenmayer T, Staudacher DL. Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenation. Artificial Organs. 2023;47(10):1654-1662. doi:10.1111/aor.14604
BibTeX
@article{Noe2023,
author = {Noe, Christian and Rottmann, Felix A and Bemtgen, Xavier and Supady, Alexander and Wengenmayer, Tobias and Staudacher, Dawid L},
title = {Dual lumen cannulation and mobilization of patients with venovenous extracorporeal membrane oxygenation},
journal = {Artificial Organs},
year = {2023},
volume = {47},
number = {10},
pages = {1654--1662},
doi = {10.1111/aor.14604}
}
EUVIMED